Tissue microarray: a simple technology that has revolutionized research in pathology.

Tissue microarray (TMA) technology is a high-throughput research tool, which has greatly facilitated and accelerated tissue analyses by in-situ technologies. TMAs are amenable to every research method that can be applied on the standard whole sections at enhanced speed. It plays a central role in target verification of results from cDNA arrays, expression profiling of tumors and tissues, and is proving to be a powerful platform for proteomic research. In this review article, primarily meant for students of pathology and oncology, we briefly discuss its basic methodology, applications and merits and limitations.

[1]  H. Moch,et al.  Tissue microarray (TMA) technology: miniaturized pathology archives for high‐throughput in situ studies , 2001, The Journal of pathology.

[2]  H. Battifora.  The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[3]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[4]  J. Saurat,et al.  Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. , 2005, The Journal of investigative dermatology.

[5]  D. Slamon,et al.  Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins. , 2001, The American journal of pathology.

[6]  I. Alafuzoff,et al.  Human brain tissue microarrays as a platform to investigate diseases of the nervous system , 2006, Brain Research.

[7]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[8]  Holger Moch,et al.  Tissue Microarrays: What Will They Bring to Molecular and Anatomic Pathology? , 2001, Advances in anatomic pathology.

[9]  F. Pontén,et al.  Analysis of Protein Expression in Cell Microarrays: A Tool for Antibody-based Proteomics , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  Michael Rasse,et al.  TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity , 2008, Modern Pathology.

[11]  D. Rimm,et al.  Validation of Tissue Microarray Technology in Breast Carcinoma , 2000, Laboratory Investigation.

[12]  S. Hewitt,et al.  Tissue microarrays as a platform for proteomic investigation , 2007, Journal of Molecular Histology.

[13]  David R. Westhead,et al.  TmaDB: a repository for tissue microarray data , 2005, BMC Bioinformatics.

[14]  S. Hewitt.  Design, construction, and use of tissue microarrays. , 2004, Methods in molecular biology.

[15]  Nirag Jhala,et al.  Diagnostic Markers That Distinguish Colon and Ovarian Adenocarcinomas: Identification by Genomic, Proteomic, and Tissue Array Profiling , 2004 .

[16]  Stephen M Hewitt,et al.  The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis , 2004, Nature Medicine.

[17]  J. Lam,et al.  Tissue Array-Based Predictions of Pathobiology, Prognosis, and Response to Treatment for Renal Cell Carcinoma Therapy , 2004, Clinical Cancer Research.

[18]  A. Baccarelli,et al.  The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study , 2006, Breast Cancer Research and Treatment.

[19]  D. Murphy,et al.  Interlaboratory comparison of immunohistochemical testing for HER2: results of the 2004 and 2005 College of American Pathologists HER2 Immunohistochemistry Tissue Microarray Survey. , 2009, Archives of pathology & laboratory medicine.

[20]  H. Battifora,et al.  The checkerboard tissue block. An improved multitissue control block. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[21]  Stephen M Hewitt,et al.  Tissue microarrays: bridging the gap between research and the clinic , 2005, Expert review of proteomics.

[22]  M. Gleave,et al.  Heat Shock Protein 27 Increases after Androgen Ablation and Plays a Cytoprotective Role in Hormone-Refractory Prostate Cancer , 2004, Cancer Research.

[23]  M. van de Rijn,et al.  Applications of microarrays to histopathology , 2004, Histopathology.

[24]  R. Romero,et al.  Tissue microarray: An effective high-throughput method to study the placenta for clinical and research purposes , 2006, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[25]  K. Pienta,et al.  Tissue Microarray Sampling Strategy for Prostate Cancer Biomarker Analysis , 2002, The American journal of surgical pathology.

[26]  A. D. De Marzo,et al.  Practical methods for tissue microarray construction. , 2005, Methods in molecular medicine.